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Abstract: 
Objective: To review the literature on rates follow-up after abnormal medical tests with a 
particular focus on follow-up after abnormal mammograms and also propose a study 
using the Carolina Mammography Registry which will 1) determine if the CMR data can 
be used for this purpose, 2) establish rates of incomplete follow-up after abnormal 
mammograms in the patients in the CMR data base, 3) compare rates of incomplete 
follow-up among participating CMR mammography centers, and 4) identify patient and 
radiological demographics associated with lower rates of follow-up after an abnormal 
screening mammogram. 
Data Sources: Most of the articles in the review portion of the paper were found via Pub-
Med searches and reports published by the Institute of Medicine. 
Design: The proposed study is a descriptive study using patients in the CMR who had an 
abnormal mammogram requiring follow-up between 1998 and 2003. The number of 
women without follow-up divided by the total number who had abnormal mammograms 
requiring follow-up will define the rate of incomplete followed-up. 
Setting: The CMR is a member of the National Cancer Institutes Breast Cancer 
Surveillance Consortium. The CMR sites include mainly community based 
mammography facilities representing hospital-based, private radiology and multi-specialty 
facilities in 39 counties in North Carolina. As of 2004, data on over 1,450,000 records on 
more that 460,000 NC women are included in the database. 
Patients: The study will include all women in the CMR aged 40 years old and older 
without personal histories of breast cancer who had abnormal screening mammograms 
by Breast Imaging and Reporting Data System (BI-RADS®) assessment in between 
January 1998 and December 2003. Those who received follow-up within three months 
and those who did not receive follow-up within three months will be compared. 
Demographic data to be extracted include: race, age, education level, family history of a 
first-degree relative with breast cancer, personal history of breast procedures, time 
interval since the last mammogram, BIRADS assessment code, recommended follow- up 
procedure, and radiology facility. Follow-up interval will be established by assessing the 
number of days in between the mammogram reading and first date pertaining to follow-up 
information. The follow-up date will be abstracted from pathology specimen laboratory 
information, date of return to a follow-up facility as ascertained by the mammography 
sites, the Lineberger Comprehensive Cancer Center's Rapid Case Ascertainment system, 
the North Carolina Cancer Registry or from other patient information supplied to a CMR 
site. 
Main outcome measure: Overall rates of abnormal screening mammograms that are not 
resolved within 3 months after the index abnormal MMG. This will be established for the 
CMR in the 1998-2003 interval and for individual radiology practices. 
Results: Rates of follow-up for the CMR will be calculated as well as rates of each 
particular mammography site. Bivariate analysis will be used to examine the relationship 
between lack of follow-up and patient and radiographic characteristics. Multivariate 
logistic regression will be performed to find the set of risk factors that best predict the 
probability of not returning for follow-up. Associations between demographic 
characteristics and the probability of not following up will be presented as adjusted odds 
ratios with 95% confidence intervals. 
Conclusions: The literature review supports the use of tracking and reminder systems 
by health care providers and care systems to improve upon the rates of follow-up after 
abnormal screening and other medical tests. We hope that findings will reveal that the 
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CMR practices have higher rates of complete patient follow-up after abnormal 
mammograms than what is detailed in the literature. This would then suggest that the 
CMR systems are effective for tracking and resolving mammographic abnormalities, thus 
provide an element of safety for its participants. Information on characteristics associated 
with more concerning rates of follow-up will then be able to guide the direction of 
improvement efforts. The information may help in the design of better systems or offer 
comparative data to stakeholders as they make decisions regarding other computerized 
data systems for their patients and staff. 
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"Serious and widespread quality problems exist throughout American medicine. 
These problems occur in small and large communities alike, in all parts of the 
country, and with approximately equal frequency in managed care and fee for 
service systems of care. Very large numbers of Americans are harmed as a 
result': 1 
IOM National Roundtable on Health Care Quality. JAMA 1998. 
Introduction: 
The Institute of Medicine (IOM) 1 has published reports outlining the 
quality problems in the US healthcare system. One of the problems is the 
inadequacy of systems to secure appropriate follow-up for abnormal medical 
tests. Such quality issues have captured the attention of the public, press, 
politicians and others charged with improving the status quo. This paper 
discusses the broader quality problems with medical testing, follow-up, and 
specifically describes the extent of this problem with breast cancer screening 
mammography. Selected reports by the 10M are reviewed for background into 
the follow-up problem while other publications are reviewed that provide 
information on what patient populations, medical care settings and study designs 
comprise some of the literature on this subject. Published recommendations to 
improve the quality of follow-up include implementing tracking and/or reminder 
systems. thus background information on aspects of these systems are also 
reviewed. Finally to add to the literature and provide information relevant to 
1 The !OM was chartered in 1970 to serve as adviser to the nation to improve health. It provides a 
service by working outside the framework of government to ensure scientifically informed 
analysis and independent guidance. The Institnte provides information and advice concerning 
health and science policy to policy-makers, professionals, leaders in every sector of society, and 
the US public. 
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patients involved in a large mammography data registry in North Carolina, we 
propose to evaluate the Carolina Mammography Registry (CMR) for its ability to 
generate overall abnormal follow-up rates for its total population and to generate 
follow-up rates for its participating mammography sites. The CMR is potentially a 
model intervention to lower rates of abnormal flu as it has the capability to 
generate automated reminders to patients and health care providers and can be 
used by the CMR staff and participating radiology sites to electronically track 
patients with unresolved breast imaging abnormalities. The short-term intent of 
this project is to reveal aspects of the CMR that may need improvements and 
provide feedback to the individual participating sites on their rates of follow-up. 
However, if it we find that the CMR system works well in supporting appropriate 
follow-up, details of the CMR can be shared with others involved in quality 
improvement efforts. The ultimate intent is to improve the quality of follow-up of 
all abnormal medical testing for broader populations. 
Background 
10M Reports 
The 10M convened the National Roundtable on Health Care Quality in 
1996 to discuss and define the quality of health care in the United States. In their 
publication The Urgent Need to Improve Health Care Quality, the writers 
separate quality problems into three major categories: Underuse, the failure to 
provide health services that would have produced favorable outcomes; Overuse; 
when a service is used under circumstances where potential harms outweigh 
benefits; and Misuse, when an otherwise appropriate service is impaired by 
action or inaction, therefore preventing the receipt of full benefits and possibly 
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even causing preventable complications. '· 2 Evidence from the literature 
indicates serious problems in all three categories 1.2_ Inappropriate follow-up, the 
focus of this paper, falls under the "misuse" category. The 10M address this 
quality problem and provides strategies to reduce errors specific to misuse in 
several of their publications discussed below. 24 
In a 1999 10M report, To Err Is Human: Building a Safer Health System, 
the strategies by which health care providers, government, industry and 
consumers can reduce preventable medical errors are provided. One of the 
reports' main conclusions is that individuals rarely cause errors in medicine. They 
are more often caused by faulty systems, processes and conditions that lead 
people to make mistakes or fail to prevent them4 . One of the authors of this 
committee's subsequent work, Crossing the Quality Chasm, gives human 
memory as an example of a pervasive and systematic safety problem that can 
influence the quality of follow-up in our health care system. 
"Suppose a patient gets hurt when a piece of information gets lost. If it 
turns out that the work design requires that someone, doctor or anyone else 
human, prevent that injury by remembering information, then we are relying on 
memory for safety. That is an element of design. But we know from decades of 
research in human factors, human cognition, and human memory, that memory 
is a terribly unreliable function .... If the heath care process relies on memory to 
function well, it will fail sometimes, no matter how hard the people in that system 
try to not forget. 2 
The reliance on memory elevates the potential for misuse in medical testing 
follow-up. Better methods to track medical information, such as the ordering and 
results of screening tests, are necessary to ensure receipt, interpretation, 
reporting and appropriate follow-up of the test results. Such "tracking systems" 
are paramount to safer systems. 
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The 10M's National Cancer Policy Board 2 specifically deals with this 
quality issue in relation to cancer screening in their report Fulfilling the Potential 
of Cancer Prevention and Early Detection5 .They outline the necessary 
operational items needed in the provider's office setting to ensure appropriate 
screening procedures. Among these are time, skills, personnel, equipment, 
adequate reimbursement, and information systems. They encourage the use of 
efficient systems that recognize patients in need of screening, enhance referral 
communication networks, and track patients and medical data to ensure the 
receipt, interpretation, reporting and appropriate follow-up of test results. 
" Tracking systems are necessary to indicate when results of screening 
tests have not been returned and to ensure the prompt and appropriate action is 
taken for patients with abnormal results" 5 
Of note, the National Cancer Policy Boards does not recommend trying to 
make changes at the individual patient level, but to make improvements at 
organizational levels such as the physician practice level, in order to see the 
greatest gains in follow-up quality. This strategy is based upon a RAND 
corporation review of 187 studies that evaluated various interventions used to 
increase the rates of colorectal, breast and cervical cancer screening services-" 
Literature Review: 
Most of the articles in the literature pertaining to the quality of follow-up 
after abnormal screening tests describe rates of follow-up in their respective 
settings and, like those of the IOM above, stress the need for tracking systems to 
improve care quality. As most are small studies on specific population groups, a 
2 National Cancer Policy Board: administered by the !OM with representation from the American 
Cancer Society, Centers for Disease Control and Prevention, National Research Council and 
National Cancer Institute. 
8 
large review article is presented first to demonstrate published ranges of follow-
up rates after cancer screening. This comprehensive review also details many of 
the demographic variables addressed in published studies that have been 
evaluated for associations with follow-up rates. A few small studies are presented 
that reflect much of what is the available in the literature specific to breast cancer 
screening follow-up. The most recent and largest population study to date is then 
reviewed. Finally articles that address reminder systems, purported to be an 
important part of the solution to inadequate follow-up rates, are reviewed for 
content and information on how they may influence physician behavior and 
patient outcomes. 
Review Article 
The largest review that describes the percentages of people who do 
not get follow-up after abnormal cancer screening tests was done by Yabroff et al. 
in 2003. These authors warn that despite increased rates of cancer screening, 
many people are still facing late-stage diagnoses, and suggest that the cause of 
this lies in a systematic problem between screening procedures and appropriate 
follow-up. 7. The authors use the term "diagnostic resolution" to describe the 
occurrence of appropriate medical follow-up for abnormal cancer screening. In 
this review, the authors focused on 45 observational studies evaluating abnormal 
colon, breast and cervical cancer screening test follow-up in the United States 
between 1980 and 2001. When all 45 papers were combined, two-thirds reported 
a lack of any kind of follow-up care for greater than 25 percent of patients, and in 
11 of the studies, the percentages of patients or specific subsets of patients 
having no follow-up were 53 percent or higher. Studies in this review reported 
even lower rates of diagnostic resolution (30-50%) in minority populations. 
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These authors detailed many demographic and health care system variables that 
are often, but not consistently, associated with higher or lower rates of follow-up. 
In their review, white race was usually associated with better follow-up rates than 
those of African-Americans, Native Americans, Asians, and Hispanics. However, 
the authors warn that other factors such as health insurance status and 
economic level may complicate the true effect of race/ethnicity.7). The variables 
often associated with better follow-up rates in include younger age, higher 
malignancy risk on mammographic interpretations, higher patient levels of social 
support, presence of health insurance, and participation in a health maintenance 
organization. In addition, factors more likely associated with better follow-up rates 
were better patient health status levels, patient's awareness of the radiologists 
assessment of their mammograms, patient's ability to recall being informed of 
their results, lower baseline fear levels pertaining to pain and cancer diagnoses, 
and having a family history of breast cancer. Healthcare system barriers 
associated with better follow-up rates included the presence of health care 
coordination methods, efficient specialty referral systems, ease of appointment 
making, shorter wait times in physician offices, higher levels of confidence in 
medical staff members, and larger sized clinics or health centers, as these may 
be more likely to have tracking systems. Other office or systems listed in this 
review with better follow-up rates include the radiology practice's ability to 
perform follow-up procedures on-sight, the presence of case managers to help 
patients negotiate through medical systems, and having provider feedback 
reporting systems. Although such variables were associated with better follow-
up rates, the overall conclusion of the review was that pervasive problems in the 
quality of follow-up exist and the authors specifically cited breast cancer 
screening as one of the areas most in need of improvement interventions. 
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Individual Articles 
Burack et al performed a descriptive retrospective chart review in a 
predominantly inner-city, African American, and Medicaid-eligible population 
between 1989 and 1996.8 The study sites involved in this review were all in 
Detroit, MI. Ninety-two consecutive patients had mammograms classified as 
"seriously abnormal" for which diagnostic ultrasound or surgical evaluation was 
recommended. The main purpose of the study was to establish the rates of 
follow-up after abnormal mammograms in this single HMO and compare their 
rates to other healthcare settings these particular authors used for comparisons. 
They also proposed to identify which patient demographics and characteristics of 
the radiologist's reporting procedures were associated with better or worse 
follow-up rates. Two trained medical record abstractors reviewed the charts after 
the index mammogram for content relating to diagnostic resolution. The authors 
chose the Health Employer Data and Information Set 3.0 (HEDIS) criterion of 60 
days to define the "appropriate" follow-up interval. Within 60 days 63/92 (67%) of 
the women lacked follow-up. By 342 days (the minimum days followed after the 
index abnormal MMG) 31/92 (66%) had lacked follow-up. Ten patients out of the 
61 (16%) who received diagnostic follow-up had breast cancer. Demographics 
variables significantly associated with lower rates of follow-up within 60 days 
included age greater than 50 and the lack of a specific follow-up 
recommendations in the radiologists report. In this somewhat homogenous 
population, they did not find significantly different rates in patients with a chronic 
illness as in the large Yabroff7 review above. Nor did they find associations with 
other variables such as receiving a clinical breast exam in association with the 
abnormal mammogram, having a primary care visit within the year prior to the 
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index mammogram, income, or education levels. They felt that for incompletely 
understood reasons, their system was less successful in helping patients get 
appropriate follow-up compared to other health care settings. Based on their 
observations, the authors challenged all HMO's to develop monitoring systems to 
assess the timely occurrence of follow-up and design programs to investigate 
barriers to follow-up. 
Kerner et al. performed a descriptive study that identified and interviewed 
184 both symptomatic and asymptomatic black, non-Hispanic women from 
Harlem and Queens, NY who had abnormalities on either clinical breast exam or 
mammogram. The author's main outcome measure was to establish their 
system's follow-up rates. The participating clinics included 2 sites in the Harlem 
community (one free standing mammography center, the Breast Examination 
Center of Harlem), and one public hospital (Harlem Hospital's Cancer Control 
Center of Harlem). The other site was a non-profit hospital in Queens, 
NY(Catholic Medical Center). All settings cared for medically underserved 
populations. The system's method for contacting patients with abnormal 
mammogram results included using follow-up letters and phone calls. Women 
are then seen for follow-up appointments 1 to 3 weeks after receiving their 
results. The study's authors identified variables associated with appropriate 
follow-up in their population. In this paper the mammographic abnormality 
studied was more serious than in other publications 9• Initially women were 
contacted as was routinely done in their practice setting. They were then re-
contacted six to eight months later. Information was obtained via in- person 
interview and via medical record review. These authors defined appropriate 
follow-up as the completion of diagnostic services within 3 months. Seventy-two 
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out of 184 (39%) of the sample lacked diagnostic resolution within this interval 
and 27.7% remained unresolved at the end of the study (180 days). Variables 
associated with better follow-up rates included having a more serious 
abnormality on BI-RADS® reading (0,4,5)3 , patient's ability to recall receipt of 
results or recall being told what was to happen next after the abnormality was 
discussed and patient recollection of asking questions during the index 
mammogram. Factors associated with lower rates of follow-up included a history 
of having a previous breast biopsy or breast abnormality and higher cancer 
anxiety scores. Multiple other variables assessed did not have statistically 
significant associations with follow-up rates. Some in particular were education 
level, family history of breast cancer, presence of health insurance, socio-
economic-status (SES), and method of results notification. Of note, these 
authors felt that the lack of SES influence in their particular study was due to a 
patient navigation system that started just prior to patient accrual, which may 
have negated an influence they originally expected to find. These authors 
suggest that certain communication factors at the time of a mammogram, which 
encourage patients to ask questions and improve the chance that a woman may 
recall the recommendations, may be an important area of focus to improve rates 
of diagnostic resolution. 
In a descriptive intervention trial by Robertson et al. the authors not only 
attempted to describe the rates of follow-up in patients with abnormal 
mammograms, but simultaneously started a new intervention which increased 
3BIRADS categories: O)needs further evaluation I) normal2) benign fmding 3)probably benign-
short interval follow-up is suggested. 4) suspicious abnormality- biopsy should be considered 
5)highly suspicious for cancer. From:http://www.birads.a1Jkategorien.html 
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the amount of communication between the radiologist and the patient's primary 
care doctor. They wanted to investigate communication problems relating to 
patient adherence to recommendations. The authors selected 63 consecutive 
mammograms read as abnormal and requiring additional imaging or biopsy from 
1,125 screening mammograms done in a two month interval at the 
Mammography Center of the Massachusetts General Hospital .10 Prior to the 
trial, this particular mammography site's method of notification included mailing 
only the initial reports to the referring physician's office. The authors investigated 
the rates of diagnostic resolution in their system after adding direct phone contact 
with the referring doctor's offices at the time of the index abnormal reading, and 
repeating letters and phone contacts to the primary care doctor if patients did not 
comply with follow-up recommendations. The authors first measured follow-up 
rates at 2 Y, months after the index mammogram. They then re-contacted the 
physician offices at 2-week intervals until the end of the study or confirmed 
diagnostic resolution of each abnormality. At the 2 1/2 month mark, 40 out of 63 
(63%) patients had not had any action taken to resolve the abnormality. After the 
first set of reminders, the numbers of outstanding abnormal tests reduced to 
10/63 (16%). At 6 months, despite the every two week reminder system, 4 
patients still did not have any known resolution of the problem. These authors 
concluded that reminder systems directed at the referring physician helped 
reduce the rates of unresolved abnormal mammograms, but they also discovered 
many reasons why the system did not work well with all patients. These included 
language barriers, provider misunderstanding of the recommendations, incorrect 
addresses and phone numbers, reports filed into patient charts without provider 
notification, and misplaced reports. The authors offered some advice on the 
design of improved follow-up systems, emphasized the need for persistence in 
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follow-up and stated the importance of a reminder system to support a successful 
breast cancer screening program. 
One of the limitations in many of the studies on this subject is the inability 
to generalize results or recommendations to larger or other populations. In an 
attempt to disentangle the effects of race, socioeconomic status, health beliefs, 
behaviors, and health care access factors on follow-up of abnormal 
mammograms, Yabroff et al. used a sample of 1,901 women from the 2000 
National Heath Interview Survey (NHIS)4 to identify characteristics associated 
with completion of follow-up after a reportedly abnormal test. 11 • All women in the 
sample were 30 years of age or older and were asked if they ever had an 
abnormal mammogram. They were then asked to list all additional test or 
procedures they received after the abnormal exam which were then coded into 
the following categories: additional imaging; clinical examination or surgical 
consult; biopsy or fine needle aspiration; breast or lump removed; or no follow-up. 
Eighty-eight percent of the sample was white, 52.5% had at least some college 
education, 97.8% had a usual source of medical care and only 5.5% stated 
having no health insurance coverage. In this group 8.6% (95% Cl 7.2-10.0%) of 
the respondents reported having no follow-up after having an abnormal 
mammogram. Although this rate is lower than most of the other published studies, 
it translates into approximately 1 million US women who had abnormal 
mammograms and did not receive follow-up. Patient demographic variables in 
their multivariate analysis associated with better follow-up included higher 
socioeconomic levels in a "dose-response pattern" (measured by education level 
4 NHIS; annual multistage household survey conducted in-person using self report. Information on 
survey design information available at www.cdc.gov/nchs/nhis.htm. 
15 
or income}, better health status levels, greater cancer risk profiles, and the 
presence of private health insurance. In contrast to other studies mentioned in 
the review above, women younger than 50 were less likely to complete follow-up 
compared to those ;:, 65. In the bivariate analysis Black, non-Hispanic, and 
Hispanic women were less likely to report follow-up than whites. However, in an 
"intermediate multivariate model" (mentioned but not detailed in the paper}, the 
association was no longer statistically significant once other demographic 
characteristics were included. 
This particular paper's authors called for future research into breast 
cancer screening processes. The authors specifically mention mammography 
registries such as those in the Breast Cancer Surveillance Consortium (BCSC} 
as potential data registries for researchers to study screening processes and to 
evaluate how the screening process relates to patient behaviors and stages of 
disease at diagnosis. The CMR, described below, is largest of the databases in 
the BCSC thus is may serve as a good source for data on follow-up quality 
issues in breast cancer screening. (See "proposed study"} 
The processes for follow up after abnormal mammograms clearly would 
benefit from improvements. Many assume these problems can be solved with the 
advent of electronic medical record systems to assist in tracking and reminding 
people about unresolved medical problems. Again, the !OM is a leader in this 
quality effort. The !OM's Committee on Data Standards for Patient Safety 
identifies eight healthcare delivery capabilities that an electronic health record 
system should posses in order to promote greater safety, quality and efficiency in 
health care delivery. Those pertaining to this paper's content include 1} having 
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test results available electronically to all stake holders for enhanced coordination 
of care, 2) offering computerized decision support to supply up-to-date guidelines 
and reminders for screening tests and other preventive measures, 3) having 
electronic communication and connectivity available to facilitate communication 
between patient, physicians, and other health care partners, 4) providing patient 
support/education, and 5) having reporting capabilities to assist in population 
health management. 12• The true effectiveness of such systems is presently 
speculative. However, there are data supporting improved practice performance 
with certain aspects of existing electronic systems. For example, Balas et al. 
reported a meta-analysis of randomized controlled trials reviewing the impact of 
prompting physicians on 16 preventive care procedures, one of which was 
mammography screening.13. Although the studies varied widely in design and 
type of reminder prompt used (e.g. electronic or paper signals to physicians 
about over-due tests, deviation from standards of care, and treatment 
recommendations}, the overall conclusion was that appropriate medical care 
actions increased with the use of reminder prompts. Although none of the 
prompts were specific to follow-up after abnormal screening tests, the study does 
give credence to the potential for such systems to improve follow-up care via the 
presence of computerized prompts. 
Kralj et al. did a similar study on oncology patients whose physicians 
were electronically reminded of laboratory data indicating low hemoglobin levels 
during chemotherapy treatments 14• They assessed the impact of an electronic 
trigger on physician's treatment of anemia with erythopoetin, a glycoprotein that 
induces red blood cell production. A four month baseline period was followed by 
a 17 month intervention period for a total of 11 ,644 physician-patient encounters 
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where patients with low hemoglobin levels were seen. One randomly selected 
community oncology practice (n=3862 patients visits) assigned to the intervention 
and a second practice which served as a control {n=7,782 patient visits) were 
compared for erythropoietin prescribing habits by their physicians. Baseline 
prescribing behaviors were similar for the two groups, but after implementation of 
the reminder system, the likelihood of an anemic patient receiving erythropoetin 
treatment increased significantly in the intervention arm. In fact in the non-
intervention arm, prescribing rates actually decreased, despite widespread 
acceptance of the practice at that time. These authors felt that reminders were 
successful and challenged researchers to continue to test other computer-based 
quality interventions to provide physicians with accurate information about the 
effectiveness of computer aids. 
Hunt et al. performed a systematic review of controlled trials performed 
since 1992 on computer based clinical decision support systems and their 
influence on physician performance and patient outcomes.15There were 19 trials 
that focused on preventive care systems, six targeting cancer prevention. All 6 -
cancer prevention studies revealed enhanced practitioner performance with 
reminder systems. 
The US can learn from other countries that primarily use electronic 
records. Sweden's medical encounters are almost entirely via electronic 
documentation. A non-randomized controlled pilot study of primary health care 
centers in a Stockholm suburb evaluated the effect of computerized screening 
test reminders. This was one of the first studies to use electronic reminders that 
were integrated directly into the electronic medical record (EMR). Reminder 
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prompts appeared on the physician's EMR at the time of a patient visit for a 
group of patients aged 70 and over. One center carried out the computer 
reminder pilot project (n=602). Three other similar sites were assigned to the 
control/usual care arm (n=1989). Five primary care preventive health tests were 
compared. There was a statistically significant increase in physician ordering of 
all 5 screening tests in the intervention arm. Based on their findings, the authors 
suggested that prompts do positively affect physician testing behavior16 Of note, 
the authors suggest that electronic reminders may be particularly effective when 
newer testing protocols emerge compared to older tests, thereby significantly 
impacting the delay that often occurs between proven and effective newer 
practice recommendations and actual physician practice. 
Although one may assume the embracement of electronic records would 
systematically improve the quality of testing follow-up, a study was done in a 
unique practice setting in the US where the electronic record system used by 
primary care providers provides full access to all laboratory data performed at 2 
medical centers17• Two hundred-sixty two internal medicine physicians practicing 
in 15 primary care practices in the Boston area were sent surveys asking about 
respective experiences with testing follow-up and notification of test results to 
patients. Of the 262 surveys mailed, 168 were completed for a response rate of 
64%. Arnong the respondents, 52% reported keeping any kind of record of what 
tests they ordered and 32% had a system to detect if a patient missed a test. 
Thirty-nine percent had a mechanism to ensure that patients with "marginally" 
abnormal mammograms received a follow-up within 6 months. Several of the 
physicians used various electronic reminders while some used paper-based 
follow-up folders. Despite the electronic capabilities, 83% percent of the 
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respondents reported reviewing at least 1 test result they wished they had known 
about "earlier" (defined as knowing the result within the a 2 month interval prior 
to actually seeing the result). Eighteen-percent of these physicians reported this 
problem occurring 5 or more times in the same interval. Only 41% felt satisfied 
with the way they managed test results. Those dissatisfied were so because of 
lack of timely review, lack of systems to track orders, and inability to detect if a 
patient failed to obtain a test. The study authors also surveyed physicians for 
what they wanted most out of electronic systems. These included a warning 
system to detect whether a patient had missed a test, listing abnormal tests 
before normal tests, and automated letter writing. The authors emphasize that 
expecting physicians to be more vigilant or spend more time on processing test 
results is unlikely to yield significant improvements in quality as already they or 
their representative spend an average of 70 minutes a day managing and 
processing test results.5 Therefore, although some technologies are in existence, 
significant strides and modifications of such systems are needed to improve the 
quality of follow-up even in electronically sophisticated US systems. 
Summary 
In summary a major quality problem identified by the 10M and multiple 
authors is that patients who have abnormal results on medical tests often do not 
have appropriate follow up. These studies involve many different patient 
populations and health care systems and suggest that large numbers of patients 
are not receiving adequate care. Most call for more research into the problem 
using larger populations to try to unravel conflicting demographic influences that 
5 Tests needing review per week averaged 800 data points from chemistry and hematology reports, 40 
radiology reports and 12 pathology reports. 
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may be responsible for different rates of follow-up. Likewise, the authors call for 
improvement interventions where problems are identified. Researchers and 
medical organizations offer similar solutions that center around tracking and 
reminder systems, often those that ideally are electronic. One such system to 
consider is the Carolina Mammography Registry (CMR) which is an electronic 
mammography screening database that has patient and physician reminder 
capabilities. The study below proposes to evaluate if the CMR can be used to 
study abnormal follow-up rates and to determine how well the CMR system 
performs in patients with abnormal screening mammograms. If such a system is 
found to have better follow-up data than what is published, aspects of the CMR 
operations may help guide the design of other computerized medical information 
systems. Likewise the researchers involved in the CMR and its partners 
comprising the Breast Cancer Surveillance Consortium can be approached to 
help answer cancer screening follow-up concerns and other process questions 
such as those suggested in this paper's background section by Yabroff et al. 11 • 
Proposed study 
To attempt to determine if rates of diagnostic resolution specific to 
abnormal mammograms are a problem in practices and patients involved in the 
CMR database, we plan to use data on women 40 and older included in the 
Carolina Mammography Registry who participated in screening mammography in 
between 1998-2003. The study aims are to 1) evaluate if this database can be 
used to address this particular question, 2) to establish the prevalence rate of 
follow-up of abnormal mammograms in the CMR, 3) to compare different CMR 
mammography site's rates of follow-up after abnormal mammograms, 4) to 
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establish if there are specific areas in which we should to focus future 
improvements on, and 5) to evaluate patient and radiological characterictics that 
may influence rates of follow-up after abnormal screening mammograms. 
Data Source and Population 
The Carolina Mammography Registry is a member of the National Cancer 
Institute's Breast Cancer Surveillance Consortium (BCSC). The BCSC was 
established in 1994 to study the performance of mammography screening in 
community practice. The consortium was created in response to a legislative 
mandate, the Mammography Quality Standards Act (1992), which granted the 
authority to devise surveillance systems to provide comprehensive data on the 
performance of breast cancer screening. The Act also required mammography 
facilities to meet quality standards and receive accreditation certificates. 18 
The CMR database is one of the largest of databases involved in the 
BCSC. As of 2004 the CMR contained data on over 1 ,450,000 records on more 
than 460,000 women from NC who had their mammograms done at one of 48 
CMR participating facilities in 39 counties in NC. Approximately 23% of screening 
aged women in NC are covered by CMR practices which represent about 25% of 
the mammography facilities in NC 19• CMR sites include hospital based, private 
radiology and multi-specialty locations. Participating radiology practices collect 
data prospectively on every patient seen for breast imaging in their facilities. The 
practices collect data on breast imaging and image guided biopsies and enter 
them into an in-house database. The patients provide self-reported demographic 
information and their medical history via a questionnare completed at the 
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beginning of each imaging visit. This questionnare is often completed with the 
help of a technologist. The mammography technologist and radiologist record the 
reason for the patient visit, the imaging provided, breast density and assessment 
of the mammogram via Breast Imaging and Reporting Data System (81-RADS®) 
category, and recommendations for future evaluations. Final patient pathological 
diagnoses and causes of death are provided from pathology settings, the North 
Carolina Cancer Registry, the Lineberger Comprehensive Cancer Center's Rapid 
Case Ascertainment program (RCA) and North Carolina death records. The 
computer software provided to the participating mammography sites provides 
tracking and reminding functions that can alert the radiology group's staff 
members about abnormal mammograms that are unresolved. Staff members can 
view electronic information on outstanding patients that includes the patient 
name, contact information, medical record number, X-ray identification numbers, 
81-RADS® assessment code, radiologist's code, follow-up recommendations, and 
date that the next screening exam is due. 
Laws put in place by the Mammography Standards act of 1992 require 
mammography facilities to contact patients and their physicians concerning 
abnormal results within 30 days of the exam. The CMR system assists radiology 
sites with complying with such Jaws. Participating practices are provided with 
electronic tracking reports, letter writing templates and yearly audit reports from 
the CMR staff and computer systems. The CMR administrative staff is available 
to the radiology sites during normal working hours for questions and trouble 
shooting. Although much of the available electronic functions need to be initiated 
by the practices themselves, the technologies and CMR support staff are 
available to help optimize system performance. The CMR staff travel to 
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participating facilities to help train new employees responsible for data entry and 
to provide on-sight problem solving. 
All data entered into the CMR database undergo extensive quality control 
at various stages of data collection and management. All identifying information 
concerning patients, radiologists and mammography sites is removed before 
analyses are performed. Protection of identifying information is strictly adhered to 
as outlined by Carney.20 The Internal Review Board at UNC-Chapel Hill approves 
CMR annually. IRS's of participating hospitals likewise are involved in the 
approval process. CMR holds a Public Health Service (PHS) certificate of 
confidentiality. 
Patient selection 
We will identify women seen for screening mammograms, who have 
abnormal results and do not return within three months. We plan to use the CMR 
data base to identify all women 40 years of age and over who presented for at 
least one screening mammogram in between 1998 and 2003 who had no record 
of follow-up concerning the index abnormal mammogram in the subsequent 3 
months. The patient visit will be considered a screening visit if they had a 
screening 2-view imaging procedure of both breasts and were asymptomatic at 
the time of the study. Subjects will be excluded if they have a history of breast 
cancer. Follow-up information will then be abstracted from the database as 
described below in the measures. If there was no follow-up information recorded 
within 3 months of the index abnormal mammogram, the database will then be 
searched for any subsequent visit up to 13 months from the abnormal 
L 
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mammogram. We expect that there will be some patients who had abnormal 
mammograms, had follow-up at a non-participating CMR sites, and then returned 
to a CMR site for subsequent screening. In this case, the subsequent 
mammogram information will be searched for information suggesting procedures 
or consultations completed since the abnormal exam. These will then serve as a 
proxy for follow-up. Those without any subsequent visit will be considered to not 
have any follow-up. 
Measures 
If the radiologist's assessment of the screening mammogram was 
abnormal by BIRADS 6 category 0, 4, 5 or a 3 with a radiologist recommendation 
for immediate follow-up, the mammogram will be identified as an abnormal 
mammogram. We will define the date of follow-up via several mechanisms: date 
of repeat visit to a CMR facility, date of pathology specimen entered via a 
pathology lab, date of pathology diagnosis as ascertained by the North Carolina 
Central Cancer Registry or via information from the Rapid Case Ascertainment 
system. Lack of follow-up within thirteen months will be identified if there are no 
other entries in the database representing a return to a CMR facility for another 
mammogram or other procedure, or a reported date from surgical pathology 
specimens. If a patient has more than one abnormal mammogram in this interval, 
the first one will be used in the analysis. If there are women who had an 
abnormal mammogram, but then had only a screening entry within the 
subsequent thirteen months, the subsequent mammogram visit notation will be 
6 The American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas 
(BI-RADS® Atlas) is the product of a collaborative effort among members of various committees 
of the American College of Radiology with cooperation from the NCI, the CDC, the FDA the 
American Medical Association, the American College of Surgeons, and the College of American 
Pathologists. 
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queried for patient documentation of new procedures listed since their index 
mammogram. Notations of procedures will then be used as a proxy for diagnostic 
follow-up as measured from the above data sources. The numbers of women 
with abnormal mammograms who have not followed up will be compared to the 
total number of women who had abnormal mammograms in each facility. This 
figure will be defined as the percentage of women without follow-up by facility. A 
missing response will be coded as a negative response to questions about 
personal and family history of breast cancer. A woman's history of having prior 
mammograms will be based on self report if there are no mammograms in the 
database assigned to her. Patients will be excluded if the BI-RADS® assessment 
code is missing. There are extensive measures taken when collecting and 
entering data into the CMR thus we do not expect to find many missing values in 
the variables for which we are interested. 
Covariates 
The study will address the relationship between lack of follow-up after an 
abnormal screening mammogram and various demographic and mammogram 
testing variables in all women in the CMR database who meet the above criteria. 
The main independent outcome variable is lack of follow-up within three months 
following an abnormal mammogram. Factors to be examined for association with 
the outcome include the following patient demographic variables: age 
(continuous), race (Black, White, Asian, American Indian, Hispanic, other) 
education level (less than 12'" grade, > or = high school), family history of breast 
cancer (yes,no), personal history of previous breast needle or surgical procedure 
(yes,no), and the time interval since the patient's last mammogram (1yr, 2yr, 3yr., 
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no previous). The factors pertaining to the screening facility and mammogram 
results include: screening assessment BIRADS® code (0,1,2,3,4,5), specific 
follow- up procedure recommended (imaging, aspiration/surgical consult/biopsy, 
or clinical exam) and mammography site. Other mammography site 
demographics can be evaluated in a secondary analysis. These may include 
number of mammograms read in one year/number of physicians reading 
mammograms in the facility, full service vs. screen-only practices, and in-house 
reading vs. sites that send out their mammograms to be read by an off-site 
radiologist. 
Analysis 
Univariate/bivariate 
We will initially examine the characteristics of the sample with univariate 
analyses to assess the distribution of the variables as well as assess any impact 
of missing data or extreme values. The mean, range, and standard deviation will 
be calculated for patient age and frequencies will be generated for the 
categorical variables. Next, we will use bivariate analysis to examine the 
relationship between lack of follow-up after an abnormal mammogram and each 
of the independent variables. Chi square tests will be used to compare 
categorical data while age will be compared to the outcome via t-tests. The 
tables (TABLE 1-4) represent what data will be collected and compared. 
Multivariate 
We will use a multivariate logistic regression model to find the set of risk 
factors that best predict the probability of not returning for follow-up. We will 
specify nominal categories as dummy variables where appropriate. A model with 
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all potential risk factors, whether significant or not in bivariate testing, will be 
estimated. We will use Likelihood ratio tests to eliminate any non-significant 
variables. The final model will consist of those predictor variables that remain 
statistically significant at p. ,;Q5, after adjustment for other variables in the model. 
Associations between characteristics of the patients or radiology sites and the 
probability of not returning for follow up will be presented as adjusted odds ratios 
with 95% confidence intervals in table format with written commentary on 
significant findings or specific items of interest. Although a predictive model will 
be used, no attempt to quantify the predictive ability of the model via validation 
techniques will be done as the entire population of the CMR data base will be 
used. 
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TABLES 
A. Univariate statistics 
Table I. Population Characteristics 
Ch aractenst1c mean ( d) # d( ) s .. or an ,_percent 
Mean age range 
Family history of breast 
cancer 
Race/ethinicity 
AA/Biack 
Hispanic 
Indian 
Asian 
Other 
Completed high school 
orGED 
Prior diagnostic breast 
procedure (biopsy or 
aspiration) 
No prior mammograms 
or none in the last 3 
years. 
Table 2. Radiology Facility Infonnation 
Ch aractenstic Nmb u d( ) er an percent 
ACR assessment code · ~,, J;;u._ .. i<i •• _ .-. 
lor2 
3 
4 
5 
0 
Action reconunended at follow up. r• 
·--.· 
,-.. ~-- ... _-..... 
Additional imaging 
Clinical follow-up 
Biopsy/aspiration/surgical evaluation 
Other Radiology site characteristics 
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B.Bivariate Statistics 
Table 3. Bivariate associations between characteristics of the population and lack of follow-up 
after an abnormal mammogram 
n mean or that did not have 
tests based on t-test continuous variables and 
Pearsons chi-square test for categorical variables. 
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Table 4. Bivariate comparisons of radiology site/assessment/recommendation and follow-up after 
an abnormal mammogram.* 
Char t ti ac ens c n oWl OU o ow-up p-va ue 
ACR assessment code 
>: 
. ....... ..,,,, . . < .. '[~\ ··.··.····.· '~i' ,; 
I or 2 
3 
4 
5 
0 
· .... 
.. 
Action recommended at follow up. 
-
''i,L~'J •·· .... ~··· .... ;~'···· 
Additional imaging 
Clinical follow-up 
Biopsy/aspiration/surgical evaluation 
Other radiology site characteristics 
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C. Multivariate Analysis: 
Table 5. 
Probability of NOT receiving follow-up after an abnormal mammogram 
Logistic Regression Estimates 
Odds Ratio C 
Mean age 
Family history ofbreast cancer t· .• ~···.·<-···-.•·t·:;i~ 
Yes 
No 
Race/ethnicity 
.······-···.······-·.···· ...••.... ·.· 
_·. · ... ·· .. • .. ·· 
.·· 
AA!black 
Hispanic 
Asian 
l high school orGED 
••. : .•.. · .....•. -••. ·.··•· ·.·.· .... ·.. > > 
Yes 
No 
Prior breast 
., ,e···-·~·· ... m.:;l 
'b1opsy or 
Yes 
No 
Prior mammograms .. ·. .• . 
. •--
_ ... , ...•... _ .;.~.·?~ 
Yes 
No 
AC:Rassessmentcode 
•• ••••• ••• ··---·-·. • .;s . 
I or 2 
3 
4 
5 
0 
Actinn 
. at follow up. 'J~b .. - }, ...••..••... _.·--· ····.-···_ .. 
Additional imaging 
]inica\ .vuv ~-up 
-, 
Other radiology site characteristics 
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Expected Findings 
The rates of follow-up after abnormal mammograms have never been 
documented using the CMR database and its participating facilities. Any 
estimates of what these may be are purely speculative. Due to the support 
systems provided by mammography site's participation in the CMR, we may find 
that rates of follow-up in this system are higher than what is seen in less 
supported sites quoted in the background literature. 
We may find some patient demographic differences in rates of follow-up 
as is reported in the literature 7. There may be lower rates of follow-up in patients 
with lower education levels, older ages, and possibly among those of different 
races or ethnicities, however disparities in utilization often reflect socioeconomic 
influences, not actual racial differences. We may find that women with a history 
of mammography use or a family history of breast cancer adhere more strictly 
with follow-up recommendations. It is difficult to speculate how the different 
radiological variables may affect follow-up rates. Higher risk BI-RADS scores 
may be associated with higher rates of follow-up as was reported by Kerner et 
a!. 91t may be that those with follow-up recommendations that imply a greater 
need for tissue sampling may likewise be associated with higher follow-up rates. 
Data pertaining to radiology sites may relate more to the study limitations 
addressed below. If practice site variations exist, we have the capability to 
investigate further into characteristics of the radiology sites, the radiologists and 
those of the referring physicians. 
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Strengths/Limitations 
The main strength of this study is the large sample size that is available 
by using the CMR data. As well, this database involves a large population where 
screening is done at the community level, thus the results are potentially more 
generalizable than those done at large academic sites. The data is collected 
over many years thus may uncover important features of the process of breast 
cancer screening and follow-up compared to other studies that evaluated 
systems over smaller time intervals. 
The main limitation of this study will likely be incomplete registry 
information on benign biopsies or procedures done at sites not participating in 
the CMR database. Although! the CMR receives complete cancer pathology from 
the Carolina Cancer Registy, there is not centralized collection of benign biopsy 
results. CMR relies on the RCA system to deliver all breast pathology. This is an 
imperfect system and not all pathology sites participate. However, If a woman 
gets a copy of her result and sends it to the mammography facility, the 
information is sent to the CMR via the data system. Although there are available 
"outcomes" data sources that can be explored for medical and pathological 
follow-up information, the reliability and consistency of use of these resources 
are not known. For example, some radiology sites keep their own follow-up 
records by contacting referring physicians or patients directly, while others do not 
track outcomes in this manner. We do not have any firm qualitative or 
quantitative data on the actual individual radiology practice's methods of tracking 
follow-up. Although CMR staff provides audit data on unresolved abnormal 
mammograms to the participating practices, no feedback from the sites is 
currently expected. 
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Another potential limitation is that CMR facilities in close proximity to non-
participating sites may appear to have lower follow-up rates. Non-CMR affiliates 
may offer second opinions or diagnostic procedures in significant numbers of 
patients originally seen at specific CMR sites, thereby making their follow-up data 
appear inferior when compared to other full service facilities. Except for loss of 
patient follow-up information in the large academic centers, this is not likely to be 
a large problem. 
Different radiology sites may have changed their practice patterns over 
the years. Some that once offered only screening mammograms have altered 
their practice structures to provide more comprehensive diagnostic capabilities. 
Therefore, the rates of documented follow-up at these sites may vary over the 
years. We have the capability to run yearly rates of follow-up and can assess for 
trends if appropriate. Patient specific factors that are not captured by the 
database may influence certain site's rates, potentially affecting how one site's 
rates compare to another with different patients. There may also be differences in 
medical culture among sites. Primary care or sub-specialty physicians in certain 
locations may take more responsibility for following and documenting patient 
follow-up compared to other areas where the radiology sites assume this role. As 
with the other factors mentioned above, such variations may affect measured 
follow-up rates. 
Discussion/ Future considerations 
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The Carolina Mammography Registry rates of non-diagnostic resolution 
have never been evaluated in this manner. Performing this study will help us 
determine if this database will be able to be used via the measures proposed to 
establish diagnostic resolution rates for our overall system and that of our 
individual practices. If it is capable of generating this information, then under 
separate funding from the Komen Foundation, a sample of women who did not 
receive follow-up will be invited to participate in a short mailed survey preceded 
by an introductory letter from their respective radiology practices and the CMR 
research staff. The goal of the survey would be to identify why patients did not 
return for follow-up or if they did, what the follow-up process entailed. We will 
explore the demographic variables associated with lower follow-up rates. Such 
information can be used by researchers interested in screening quality to better 
focus efforts on at-risk populations. Researchers interested in testing alternate 
forms of communications with patients (eg. patient navigators, lay-health 
advisors, E-mail or web based systems) may also benefit from our findings. We 
plan to bring significant findings to our partners in the Breast Cancer Surveillance 
Consortium. This may encourage other investigators to apply similar methods to 
their databases and increase the amount of follow-up information available on 
other or larger populations. 
The practices themselves may benefit from feedback data concerning 
their particular patient's rates of follow-up. This information may motivate those 
with high quality follow-up data to continue their efforts or encourage practices 
with less robust follow-up to employ existing CMR tracking and reminder 
technologies. Research studies involving focus groups or surveys of the 
radiology practices could provide important information explaining respective 
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rates of abnormal follow-up such as of barriers they have with using the available 
software. Communication breakdowns may be of particular interest. The role of 
the primary care physician in patient adherence to follow-up is of particular 
interest to one of our investigators and may be the focus of future research. 
Alternatively, the findings may assist in designing higher quality tracking 
processes. Many of the CMR practices are currently making decisions about 
new electronic systems used by hospitals or other organizations with which they 
interface. Data from our study may assist them while weighing decisions about 
proposed data systems. The results from the study may also be important for the 
radiology groups to share with various stakeholders like director's boards, 
managed care groups or government agencies. 
The group we are most interested in helping is the women themselves. 
The work by Yabroff already discussed raises an important question concerning 
the quality of our screening systems. If people comply with screening 
recommendations, but are not adequately follow-up in a timely manner, the 
potential for screening to affect the quality of patient's lives is in jeopardy. All of 
the recent attentions the press and agencies like the 10M are giving to quality 
problems in American medicine truly create a "teachable moment" for 
improvements that may be suggested by our data. We feel that our work will 
contribute to these efforts, especially if researchers act upon the findings. If it is 
found that the CMR systems is particularly effective, the useful aspects of the 
system can be shared with others working to improve the quality of follow-up 
care. We hope that our database and others like it can ultimately assist in 
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providing information used to design safer systems to address this critical quality 
problem in US health care system. 
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